Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Paracetamol,Caffeine
Therapeutic Area : Immunology
Study Phase : Approved
Recipient : Famar
Deal Size : Undisclosed
Deal Type : Collaboration
FAMAR and Lavipharm Collaborate on Pharmaceutical Product Production
Details : Under the collaboration, FAMAR will produce two analgesic pharmaceutical products for Lavipharm: Lonarid N (paracetamol) and Lonalgal (caffeine anhydrous).
Brand Name : Lonarid N
Molecule Type : Small molecule
Upfront Cash : Undisclosed
January 23, 2024
Lead Product(s) : Paracetamol,Caffeine
Therapeutic Area : Immunology
Highest Development Status : Approved
Recipient : Famar
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?